+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab



Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab



Transplantation Proceedings 38(8): 2659-2660



In contrast to focal segmental glomerulosclerosis, which is well known to recur early in a renal graft, there are only few cases described with recurrence of immunoglobulin M (IgM) nephropathy after transplantation. We herein describe a patient with early recurrence of IgM nephropathy. A 15-year-old boy with nephrotic syndrome (IgM nephropathy) proceeding to end-stage renal disease was on dialysis before living related renal transplantation. Native kidneys were not removed. Standard immunosuppression including steroids, tacrolimus, and mycophenolate mofetil yielded initially good graft function with the s-creatinine falling to 73 micromol/L. Proteinuria was present on day 1, increasing to 20 g/L after 3 days. S-creatinine increased to 158 micromol/L and urine production diminished. A graft biopsy showed no rejection or glomerulopathy but protein vacuoles were seen within tubular cells indicating massive proteinuria. Treatment with plasma exchanges, immunoglobulin, and steroids was started. Hemodialysis was necessary. Proteinuria improved to 3.5 g/L, but s-creatinine continued to rise and a second graft biopsy showed vascular rejection (Banff type IIA). The patient was treated with antithymocyte globulin and further plasma exchanges. A single dose of rituximab was given. Five months after transplantation the s-creatinine was 67 micromol/L and there was no proteinuria. In this case early recurrence of nephrotic syndrome occurred on the first posttransplant day in combination with later occurring vascular rejection. Successful treatment included a combination of plasma exchanges, rituximab, immunoglobulin, and antithymocyte globulin.

(PDF emailed within 0-6 h: $19.90)

Accession: 012852219

Download citation: RISBibTeXText

PMID: 17098031

DOI: 10.1016/j.transproceed.2006.07.034


Related references

Recurrence of immunoglobulin A nephropathy with immunoglobulin A antineutrophil cytoplasmic antibodies following renal transplantation. American Journal of Kidney Diseases 29(1): 125-131, 1997

Rejection-triggered haemophagocytic syndrome in renal transplantation successfully treated with intravenous immunoglobulin. Clinical Kidney Journal 6(5): 530-532, 2013

Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type. Pediatric Transplantation 16(5): E183-E187, 2012

A case of nephrotic syndrome with immunoglobulin e antibodies to many allergens treated successfully with tranilast. Japanese Journal of Allergology 33(8): 433-439, 1984

Recurrence of mesangial immunoglobulin a nephropathy after renal transplantation. D'amico, G , L Minetti And C Ponticelli (Ed ) Contributions to Nephrology, Vol 40 Iga Mesangial Nephropathy; Meeting, Milano, Italy, Oct 3-4, 1983 X+308p S Karger: Basel, Switzerland; New York, N Y , Usa Illus 195-197, 1984

Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. American Journal of Kidney Diseases 28(1): 99-104, 1996

Risk factors for recurrence of immunoglobulin a nephropathy after renal transplantation: single center study. Therapeutic Apheresis and Dialysis 17(2): 213-220, 2013

Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome. Pediatric Transplantation 19(5): E115-E120, 2016

Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. Journal of Clinical Investigation 71(5): 1342-1347, 1983

Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin. Scandinavian Journal of Rheumatology 46(5): 413-414, 2016

Different Recurrence Rates Between Pediatric and Adult Renal Transplant for Immunoglobulin A Nephropathy: Predictors of Posttransplant Recurrence. Experimental and Clinical Transplantation 13(3): 227-232, 2016

Clinical outcomes of nephrotic syndrome in immunoglobulin a nephropathy. Saudi Journal of Kidney Diseases and Transplantation 28(6): 1314-1320, 2017

Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatric Transplantation 5(6): 406-409, 2001

Nephrotic syndrome related to immunoglobulin M nephropathy and hypothyroidism: An uncommon association. Saudi Journal of Kidney Diseases and Transplantation 27(4): 828-829, 2017

A case of immunoglobulin A nephropathy treated successfully with tonsillectomy and steroid pulse therapy 20A years after onset. 2013